172 related articles for article (PubMed ID: 23666780)
21. Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.
Morganti M; Coronnello M; Caciagli B; Biondi C; Quattrone A; Capaccioli S; Mazzei T; Mini E
Anticancer Drugs; 2000 Apr; 11(4):285-94. PubMed ID: 10898545
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow.
Belur LR; Boelk-Galvan D; Diers MD; McIvor RS; Zimmerman CL
Cancer Res; 2001 Feb; 61(4):1522-6. PubMed ID: 11245460
[TBL] [Abstract][Full Text] [Related]
23. Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase.
Jonnalagadda M; Brown CE; Chang WC; Ostberg JR; Forman SJ; Jensen MC
Gene Ther; 2013 Aug; 20(8):853-60. PubMed ID: 23303282
[TBL] [Abstract][Full Text] [Related]
24. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
[TBL] [Abstract][Full Text] [Related]
25. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
Sastry KJ; Chan TS; Rodriguez LV
Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
[TBL] [Abstract][Full Text] [Related]
26. Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity.
May C; Gunther R; McIvor RS
Blood; 1995 Sep; 86(6):2439-48. PubMed ID: 7662992
[TBL] [Abstract][Full Text] [Related]
27. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
Volpato JP; Fossati E; Pelletier JN
J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
[TBL] [Abstract][Full Text] [Related]
28. Transfection of DHFR- and DHFR+ mammalian cells using methotrexate-resistant mutants of mouse dihydrofolate reductase.
Thillet J; Pictet R
FEBS Lett; 1990 Sep; 269(2):450-3. PubMed ID: 2401371
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation.
James R; May C; Diers M; Wagner J; McIvor R
Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690
[TBL] [Abstract][Full Text] [Related]
30. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.
Banerjee D; Zhao SC; Tong Y; Steinherz J; Gritsman K; Bertino JR
Cancer Gene Ther; 1994 Sep; 1(3):181-4. PubMed ID: 7621249
[TBL] [Abstract][Full Text] [Related]
31. Maintenance of differential methotrexate toxicity between cells expressing drug-resistant and wild-type dihydrofolate reductase activities in the presence of nucleosides through nucleoside transport inhibition.
Warlick CA; Sweeney CL; McIvor RS
Biochem Pharmacol; 2000 Jan; 59(2):141-51. PubMed ID: 10810448
[TBL] [Abstract][Full Text] [Related]
32. Isolation and characterization of a dihydrofolate reductase gene mutation in methotrexate-resistant Drosophila cells.
Hao H; Tyshenko MG; Walker VK
Gene Expr; 1996; 6(4):231-9. PubMed ID: 9196078
[TBL] [Abstract][Full Text] [Related]
33. Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance.
Morris JA; McIvor RS
Biochem Pharmacol; 1994 Mar; 47(7):1207-20. PubMed ID: 8161350
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T
Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121
[TBL] [Abstract][Full Text] [Related]
35. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR
J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962
[TBL] [Abstract][Full Text] [Related]
36. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
37. Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic-leukaemia (HL-60) cells. Lack of correlation between increased activity and overproduction.
Dedhar S; Hartley D; Goldie JH
Biochem J; 1985 Feb; 225(3):609-17. PubMed ID: 3856428
[TBL] [Abstract][Full Text] [Related]
38. A single point mutation in Drosophila dihydrofolate reductase confers methotrexate resistance to a transgenic CHO cell line.
Neumann K; Al-Batayneh KM; Kuiper MJ; Parsons-Sheldrake J; Tyshenko MG; Flintoff WF; Cole SP; Walker VK
Genome; 2003 Aug; 46(4):707-15. PubMed ID: 12897877
[TBL] [Abstract][Full Text] [Related]
39. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells.
Arrebola R; Olmo A; Reche P; Garvey EP; Santi DV; Ruiz-Perez LM; Gonzalez-Pacanowska D
J Biol Chem; 1994 Apr; 269(14):10590-6. PubMed ID: 8144647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
